We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$244M
AUM Growth
-$11.5M
Cap. Flow
-$17.8M
Cap. Flow %
-7.28%
Top 10 Hldgs %
27.75%
Holding
287
New
30
Increased
69
Reduced
110
Closed
41

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$14.6M
2
DIS icon
Walt Disney
DIS
+$10.3M
3
GILD icon
Gilead Sciences
GILD
+$10.2M
4
ABBV icon
AbbVie
ABBV
+$9.79M
5
NLSN
Nielsen Holdings plc
NLSN
+$4.28M

Top Sells

Rank Stock Value
1
CXW icon
CoreCivic
CXW
+$6.9M
2
GEO icon
The GEO Group
GEO
+$6.36M
3
MDU icon
MDU Resources
MDU
+$6.33M
4
SBRA icon
Sabra Healthcare REIT
SBRA
+$5.72M
5
CNA icon
CNA Financial
CNA
+$5.55M

Sector Composition

Rank Sector Weight
1 Healthcare 19.36%
2 Communication Services 10.2%
3 Technology 10.03%
4 Industrials 8.75%
5 Materials 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLTR icon
26
Dollar Tree
DLTR
$24.2B
$1.66M 0.68%
21,014
-292
-1% -$26.3K
PFE icon
27
Pfizer
PFE
$143B
$1.61M 0.66%
50,067
-11,013
-18% -$368K
PEP icon
28
PepsiCo
PEP
$187B
$1.61M 0.66%
14,787
+75
+0.5% +$8.08K
XOM icon
29
ExxonMobil
XOM
$611B
$1.6M 0.66%
18,345
-2,006
-10% -$178K
GE icon
30
GE Aerospace
GE
$364B
$1.6M 0.65%
11,274
-2,560
-19% -$382K
DUK icon
31
Duke Energy
DUK
$97.5B
$1.59M 0.65%
19,815
-2,839
-13% -$235K
DD
32
DELISTED
Du Pont De Nemours E I
DD
$1.57M 0.64%
23,425
-2,620
-10% -$178K
AZN icon
33
AstraZeneca
AZN
$262B
$1.54M 0.63%
23,474
-203
-0.9% -$13.3K
ETN icon
34
Eaton
ETN
$155B
$1.49M 0.61%
22,694
-12,576
-36% -$813K
TTC icon
35
Toro Company
TTC
$8.99B
$1.43M 0.58%
30,497
+2,487
+9% +$116K
APH icon
36
Amphenol
APH
$186B
$1.41M 0.58%
87,108
-2,044
-2% -$31.1K
VZ icon
37
Verizon
VZ
$182B
$1.4M 0.57%
26,980
-2,357
-8% -$127K
KWR icon
38
Quaker Houghton
KWR
$2.62B
$1.4M 0.57%
13,200
-10,000
-43% -$976K
ELV icon
39
Elevance Health
ELV
$80.9B
$1.39M 0.57%
11,128
+1,607
+17% +$207K
BCR
40
DELISTED
CR Bard Inc.
BCR
$1.39M 0.57%
6,201
+525
+9% +$118K
MRK icon
41
Merck
MRK
$315B
$1.35M 0.55%
22,666
-9,834
-30% -$575K
EBAY icon
42
eBay
EBAY
$49.8B
$1.34M 0.55%
40,817
-1,041
-2% -$31.4K
FDS icon
43
Factset
FDS
$9.18B
$1.34M 0.55%
8,260
+739
+10% +$127K
IQV icon
44
IQVIA
IQV
$34.4B
$1.31M 0.54%
16,186
-356
-2% -$27K
GSK icon
45
GSK
GSK
$104B
$1.3M 0.53%
24,034
-1,278
-5% -$70.1K
RHT
46
DELISTED
Red Hat Inc
RHT
$1.29M 0.53%
15,958
+328
+2% +$24.4K
ROST icon
47
Ross Stores
ROST
$74.9B
$1.28M 0.53%
19,983
-445
-2% -$27.4K
EFX icon
48
Equifax
EFX
$21.1B
$1.28M 0.52%
9,487
-212
-2% -$28.1K
INCY icon
49
Incyte
INCY
$23.4B
$1.27M 0.52%
13,522
+3,472
+35% +$293K
ROP icon
50
Roper Technologies
ROP
$36.6B
$1.27M 0.52%
6,940
+14
+0.2% +$2.44K
1
2
3 4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2016 Portfolio in Review

As of Q3 2016, Stanley-Laman Group held 287 positions worth $244M, down 4.5% from $256M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Stanley-Laman Group withdrew a net $17.8M in Q3 2016, closing 41 positions and reducing 110 holdings. Its most notable exit was CoreCivic, an estimated $6.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 11% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Stanley-Laman Group opened a new position in Monsanto Co worth $14.3M.

  • Stanley-Laman Group's largest Q3 2016 buy was Monsanto Co: 139,510 shares worth $14.3M.
  • Stanley-Laman Group added most to Gilead Sciences in Q3 2016, an estimated $10.2M increase.
  • Stanley-Laman Group's biggest Q3 2016 reduction was Sabra Healthcare REIT, cutting an estimated $5.72M.
  • Stanley-Laman Group fully exited CoreCivic in Q3 2016, selling an estimated $6.9M.
  • Stanley-Laman Group's ten largest holdings make up 28% of its $244M portfolio in Q3 2016.
  • Stanley-Laman Group opened 30 new positions and closed 41 in Q3 2016.
  • Stanley-Laman Group's portfolio value fell 4.5% quarter-over-quarter to $244M.

Based on Stanley-Laman Group's 13F filing for Q3 2016, filed 28 Oct 2016.